ACAD
27.64
-1.37
-4.72%
AEMD
2.15
-0.03
-1.38%
APRI
1.09
+0.02
+1.87%
ARNA
15.23
+0.15
+0.99%
ATEC
1.79
-0.06
-3.24%
CNAT
5.46
-0.13
-2.33%
CRXM
0.175
0.00
0.00%
CYTX
1.16
+0.08
+7.41%
DXCM
74.94
-2.81
-3.61%
GNMK
12.24
-0.35
-2.78%
HALO
13.99
-0.6
-4.11%
ILMN
176.36
-4.53
-2.50%
INNV
0.111
-0.009
-7.423%
INO
8.12
-0.26
-3.10%
ISCO
1.15
+0.02
+1.77%
ISIS
57.56
0.00
0.00%
LGND
119.16
-3.15
-2.58%
LPTN
2.93
-0.08
-2.66%
MBVX
1.44
-0.02
-1.37%
MEIP
2.34
0.00
0.00%
MNOV
5.26
-0.2
-3.66%
MRTX
3.75
-0.3
-7.41%
MSTX
0.131
-0.007
-5.278%
NBIX
45.56
-1.75
-3.70%
NUVA
75.54
-1.15
-1.50%
ONCS
1.18
+0.07
+6.31%
ONVO
2.66
-0.08
-2.92%
OREX
3.08
+0.05
+1.65%
OTIC
18.45
-0.5
-2.64%
QDEL
27.16
-0.17
-0.62%
RCPT
231.96
0.00
0.00%
RGLS
1.05
+0.03
+2.94%
RMD
77.02
-0.67
-0.86%
SCIE
0
0.00
-7.69231%
SPHS
2.41
+0.3
+14.22%
SRNE
2.05
-0.05
-2.38%
TROV
1.065
-0.055
-4.911%
VICL
2.54
+0.06
+2.42%
VOLC
18
0.00
0.00%
ZGNX
14.3
-0.45
-3.05%
ACAD
27.64
-1.37
-4.72%
AEMD
2.15
-0.03
-1.38%
APRI
1.09
+0.02
+1.87%
ARNA
15.23
+0.15
+0.99%
ATEC
1.79
-0.06
-3.24%
CNAT
5.46
-0.13
-2.33%
CRXM
0.175
0.00
0.00%
CYTX
1.16
+0.08
+7.41%
DXCM
74.94
-2.81
-3.61%
GNMK
12.24
-0.35
-2.78%
HALO
13.99
-0.6
-4.11%
ILMN
176.36
-4.53
-2.50%
INNV
0.111
-0.009
-7.423%
INO
8.12
-0.26
-3.10%
ISCO
1.15
+0.02
+1.77%
ISIS
57.56
0.00
0.00%
LGND
119.16
-3.15
-2.58%
LPTN
2.93
-0.08
-2.66%
MBVX
1.44
-0.02
-1.37%
MEIP
2.34
0.00
0.00%
MNOV
5.26
-0.2
-3.66%
MRTX
3.75
-0.3
-7.41%
MSTX
0.131
-0.007
-5.278%
NBIX
45.56
-1.75
-3.70%
NUVA
75.54
-1.15
-1.50%
ONCS
1.18
+0.07
+6.31%
ONVO
2.66
-0.08
-2.92%
OREX
3.08
+0.05
+1.65%
OTIC
18.45
-0.5
-2.64%
QDEL
27.16
-0.17
-0.62%
RCPT
231.96
0.00
0.00%
RGLS
1.05
+0.03
+2.94%
RMD
77.02
-0.67
-0.86%
SCIE
0
0.00
-7.69231%
SPHS
2.41
+0.3
+14.22%
SRNE
2.05
-0.05
-2.38%
TROV
1.065
-0.055
-4.911%
VICL
2.54
+0.06
+2.42%
VOLC
18
0.00
0.00%
ZGNX
14.3
-0.45
-3.05%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …